Publications by authors named "Felicitas Hitz"

Claim this Profile
P
Predictors of Multidisciplinary Tumor Board Adherence in Stage III Non-Small-Cell Lung Cancer Patients From a Large Multicenter Study.
Kira-Lee Koster, Sarvaganthasenay Yohasenan, Ahmet Samil Pakmak, Michael Mark, Yannis Metaxas, Felicitas Hitz

Clin Lung Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positron Emission Tomography-Guided Brentuximab Vedotin, Etoposide, Cyclophosphamide, Doxorubicin, Dacarbazine, and Dexamethasone in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma: A Prospective, Multicenter, Single-Arm, Phase II Cohort of the German Hodgkin Study Group HD21 Trial.
Justin Ferdinandus, Helen Kaul, Alexander Fosså, Andreas Hüttmann, Felix Keil, Felicitas Hitz

J Clin Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updated recommendations for the treatment of light-chain amyloidosis from the Swiss Amyloidosis Network.
Max J Rieger, Andreas J Flammer, Sabine Gerull, Thomas Pabst, Holger W Auner, Felicitas Hitz

Swiss Med Wkly· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Six-month rituximab-lenalidomide regimen in advanced untreated follicular lymphoma: SAKK 35/10 trial 10-year update.
Eva Kimby, Sämi Schär, Maria Cristina Pirosa, Anna Vanazzi, Ulrich M Mey, Felicitas Hitz

Blood Adv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blastic plasmacytoid dendritic cell neoplasm: a Swiss case series of a very rare disease and a structured review of the literature.
Ramona Meier-Lienhard, Cosima Suter, Thomas Pabst, Felicitas Hitz, Jakob R Passweg

Swiss Med Wkly· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcome of peripheral T-cell lymphomas: Ten-year follow-up of the International Prospective T-cell Project.
Monica Civallero, Joseph G Schroers-Martin, Steven Horwitz, Martina Manni, Yana Stepanishyna, Felicitas Hitz

Br J Haematol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Historic characteristics and mortality of patients in the Swiss Amyloidosis Registry.
Sofie Brouwers, Raphael Heimgartner, Natallia Laptseva, Adriano Aguzzi, Niklas F Ehl, Felicitas Hitz, Frank Ruschitzka

Swiss Med Wkly· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematopoietic cell transplantation and cellular therapies in Switzerland. Evolution over 25 years. A report from the stem cell transplantation and cellular therapies working groups of the SBST 1997-2021.
Jakob R Passweg, Helen Baldomero, Marc Ansari, Caroline Arber, Yves Chalandon, Felicitas Hitz

Hematol Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The SALENTO prognostic model for limited-stage peripheral T-cell lymphoma from the International T-Cell Project Network.
Greg Hapgood, Monica Civallero, Yana Stepanishyna, Julie Vose, Monica Elena Cabrera, Felicitas Hitz

Blood Adv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decision-Making among Experts in Advanced Hodgkin Lymphoma.
Felicitas Hitz, Noémie Lang, Ulrich Mey, Walter Mingrone, Alden Moccia

Oncology· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of older myeloma patients in relationship to comorbidities and availability of second-generation novel agents in a real-life setting.
Murielle Lalive d'Epinay, Sabine Güsewell, Nicole Graf, Ulrich J M Mey, Christoph Driessen, Felicitas Hitz

Hematol Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Team functioning across different tumour types: Insights from a Swiss cancer center using qualitative and quantitative methods.
Felicitas Hitz, Karin Ribi, Gudela Grote, Michaela Kolbe, Christof Schmitz

Cancer Rep (Hoboken)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SAKK 35/15: a phase 1 trial of obinutuzumab in combination with venetoclax in patients with previously untreated follicular lymphoma.
Anastasios Stathis, Ulrich Mey, Sämi Schär, Felicitas Hitz, Christiane Pott

Blood Adv· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive value of baseline metabolic tumor volume in early-stage favorable Hodgkin Lymphoma - Data from the prospective, multicenter phase III HD16 trial.
Lutz van Heek, Colin Stuka, Helen Kaul, Horst Müller, Jasmin Mettler, Felicitas Hitz

BMC Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic and phenotypic attributes of splenic marginal zone lymphoma.
Ferdinando Bonfiglio, Alessio Bruscaggin, Francesca Guidetti, Lodovico Terzi di Bergamo, Martin Faderl, Felicitas Hitz

Blood· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial of inotuzumab ozogamicin in combination with temsirolimus in patients with relapsed or refractory CD22-positive B-cell non-Hodgkin lymphomas.
Maria C Pirosa, Lu Zhang, Felicitas Hitz, Urban Novak, Dagmar Hess

Leuk Lymphoma· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project.
Ranjana H Advani, Tetiana Skrypets, Monica Civallero, Michael A Spinner, Martina Manni, Felicitas Hitz

Blood· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial.
Stefanie Kreissl, Helen Goergen, Ina Buehnen, Carsten Kobe, Alden Moccia, Felicitas Hitz

Lancet Haematol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged rituximab maintenance in follicular lymphoma patients: long-term results of the SAKK 35/03 randomized trial.
Alden A Moccia, Christian Taverna, Sämi Schär, Anna Vanazzi, Stéphanie Rondeau, Felicitas Hitz

Blood Adv· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial.
Rudolf Benz, Kornelius Arn, Martin Andres, Thomas Pabst, Michael Baumann, Felicitas Hitz

Blood Adv· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project.
Christopher P Fox, Monica Civallero, Young-Hyeh Ko, Martina Manni, Tetiana Skrypets, Felicitas Hitz

Lancet Haematol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does progress achieved in the treatment of patients with metastatic non-small-cell lung cancer reach the elderly population? A cohort study from a cancer centre from Eastern Switzerland.
Sabine Schmid, Jorune Suipyte, Christian Herrmann, Mohsen Mousavi, Felicitas Hitz

Eur J Cancer Care (Engl)· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melphalan dose in myeloma patients ≥65 years of age undergoing high-dose therapy and autologous stem cell transplantation: a multicentric observational registry study.
Guido Ghilardi, Thomas Pabst, Barbara Jeker, Rouven Müller, Anne Cairoli, Felicitas Hitz

Bone Marrow Transplant· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy.
Emanuele Zucca, Stephanie Rondeau, Anna Vanazzi, Bjørn Østenstad, Ulrich J M Mey, Felicitas Hitz

Blood· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Promising activity of nelfinavir-bortezomib-dexamethasone in proteasome inhibitor-refractory multiple myeloma.
Christoph Driessen, Rouven Müller, Urban Novak, Nathan Cantoni, Daniel Betticher, Felicitas Hitz

Blood· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis